MustGrow Biologics Corp
XTSX:MGRO
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.54
1.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
MustGrow Biologics Corp
Operating Income
MustGrow Biologics Corp
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
MustGrow Biologics Corp
XTSX:MGRO
|
Operating Income
-CA$5.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Operating Income
-$314.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-138%
|
CAGR 10-Years
N/A
|
|
|
Cardiol Therapeutics Inc
TSX:CRDL
|
Operating Income
-CA$36.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Operating Income
-$79.2m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Operating Income
$87m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Willow Biosciences Inc
TSX:WLLW
|
Operating Income
-CA$3.1m
|
CAGR 3-Years
49%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
MustGrow Biologics Corp
Glance View
MustGrow Biologics Corp. engages in the development and commercialization of natural biopesticide products from mustard seed. The company is headquartered in Saskatoon, Saskatchewan. The company went IPO on 2019-07-10. The firm is focused on providing natural science-based biological solutions for high value crops, including fruits and vegetables, and other industries. The company has designed and owns a natural solution, which uses the mustard seed's natural defense mechanism to protect plants from pests and diseases. The product, in granule format, is available across all key United states and by Health Canada's Pest Management Regulatory Agency (PMRA) as a biopesticide for high value crops, such as in fruit and vegetables. The company concentrates on a mustard extract biopesticide in liquid format, TerraMG and could be applied through standard drip or spray equipment, improving functionality and performance features. In addition, the Company's mustard-derived extract technologies could have other applications in several different industries from preplant soil treatment, to weed control, to postharvest disease control and food preservation.
See Also
What is MustGrow Biologics Corp's Operating Income?
Operating Income
-5.1m
CAD
Based on the financial report for Dec 31, 2024, MustGrow Biologics Corp's Operating Income amounts to -5.1m CAD.
What is MustGrow Biologics Corp's Operating Income growth rate?
Operating Income CAGR 3Y
-19%
Over the last year, the Operating Income growth was -535%. The average annual Operating Income growth rates for MustGrow Biologics Corp have been -19% over the past three years .